109 related articles for article (PubMed ID: 15939798)
1. The reduced folate carrier gene is a novel selectable marker for recombinant protein overexpression.
Rothem L; Berman B; Stark M; Jansen G; Assaraf YG
Mol Pharmacol; 2005 Sep; 68(3):616-24. PubMed ID: 15939798
[TBL] [Abstract][Full Text] [Related]
2. Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells.
Kühnel JM; Chiao JH; Sirotnak FM
J Cell Physiol; 2000 Sep; 184(3):364-72. PubMed ID: 10911368
[TBL] [Abstract][Full Text] [Related]
3. 5-amino-4-imidazolecarboxamide riboside potentiates both transport of reduced folates and antifolates by the human reduced folate carrier and their subsequent metabolism.
McGuire JJ; Haile WH; Yeh CC
Cancer Res; 2006 Apr; 66(7):3836-44. PubMed ID: 16585211
[TBL] [Abstract][Full Text] [Related]
4. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis.
Jansen G; van der Heijden J; Oerlemans R; Lems WF; Ifergan I; Scheper RJ; Assaraf YG; Dijkmans BA
Arthritis Rheum; 2004 Jul; 50(7):2130-9. PubMed ID: 15248210
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier.
Wang Y; Zhao R; Goldman ID
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6256-64. PubMed ID: 15448015
[TBL] [Abstract][Full Text] [Related]
6. Folate uptake in the human intestine: promoter activity and effect of folate deficiency.
Subramanian VS; Chatterjee N; Said HM
J Cell Physiol; 2003 Aug; 196(2):403-8. PubMed ID: 12811835
[TBL] [Abstract][Full Text] [Related]
7. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo.
Mauritz R; Peters GJ; Kathmann I; Teshale H; Noordhuis P; Comijn EM; Pinedo HM; Jansen G
Cancer Chemother Pharmacol; 2008 Nov; 62(6):937-48. PubMed ID: 18283461
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier.
Zhao R; Gao F; Babani S; Goldman ID
Clin Cancer Res; 2000 Aug; 6(8):3304-11. PubMed ID: 10955817
[TBL] [Abstract][Full Text] [Related]
10. Restoration of high-level transport activity by human reduced folate carrier/ThTr1 thiamine transporter chimaeras: role of the transmembrane domain 6/7 linker region in reduced folate carrier function.
Liu XY; Witt TL; Matherly LH
Biochem J; 2003 Jan; 369(Pt 1):31-7. PubMed ID: 12227830
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the reduced-folate carrier affect protein localization and stability.
Sadlish H; Murray RC; Williams FM; Flintoff WF
Biochem J; 2000 Mar; 346 Pt 2(Pt 2):509-18. PubMed ID: 10677373
[TBL] [Abstract][Full Text] [Related]
12. Loss of reduced folate carrier function and folate depletion result in enhanced pemetrexed inhibition of purine synthesis.
Zhao R; Zhang S; Hanscom M; Chattopadhyay S; Goldman ID
Clin Cancer Res; 2005 Feb; 11(3):1294-301. PubMed ID: 15709201
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of the reduced folate carrier, the major membrane transporter for methotrexate, in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Ge Y; Haska CL; LaFiura K; Devidas M; Linda SB; Liu M; Thomas R; Taub JW; Matherly LH
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):451-7. PubMed ID: 17255265
[TBL] [Abstract][Full Text] [Related]
14. Alterations in the expression of transcription factors and the reduced folate carrier as a novel mechanism of antifolate resistance in human leukemia cells.
Rothem L; Aronheim A; Assaraf YG
J Biol Chem; 2003 Mar; 278(11):8935-41. PubMed ID: 12519783
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a cysteine-less human reduced folate carrier: localization of a substrate-binding domain by cysteine-scanning mutagenesis and cysteine accessibility methods.
Cao W; Matherly LH
Biochem J; 2003 Aug; 374(Pt 1):27-36. PubMed ID: 12749765
[TBL] [Abstract][Full Text] [Related]
16. A humanized mouse model for the reduced folate carrier.
Patterson D; Graham C; Cherian C; Matherly LH
Mol Genet Metab; 2008 Feb; 93(2):95-103. PubMed ID: 17983788
[TBL] [Abstract][Full Text] [Related]
17. Localization of a human reduced folate carrier protein in the mitochondrial as well as the cell membrane of leukemia cells.
Trippett TM; Garcia S; Manova K; Mody R; Cohen-Gould L; Flintoff W; Bertino JR
Cancer Res; 2001 Mar; 61(5):1941-7. PubMed ID: 11280750
[TBL] [Abstract][Full Text] [Related]
18. Primary acute lymphoblastic leukemia cells use a novel promoter and 5'noncoding exon for the human reduced folate carrier that encodes a modified carrier translated from an upstream translational start.
Flatley RM; Payton SG; Taub JW; Matherly LH
Clin Cancer Res; 2004 Aug; 10(15):5111-22. PubMed ID: 15297414
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of reduced folate carrier may result in folate malabsorption across intestinal brush border membrane during experimental alcoholism.
Hamid A; Wani NA; Rana S; Vaiphei K; Mahmood A; Kaur J
FEBS J; 2007 Dec; 274(24):6317-28. PubMed ID: 18005257
[TBL] [Abstract][Full Text] [Related]
20. Antifolate resistance in a HeLa cell line associated with impaired transport independent of the reduced folate carrier.
Zhao R; Chattopadhyay S; Hanscom M; Goldman ID
Clin Cancer Res; 2004 Dec; 10(24):8735-42. PubMed ID: 15623659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
